Literature DB >> 21401622

Hypergammaglobulinemia in an SIV-infected rhesus macaque with a B-cell neoplasm with plasma cell differentiation.

Joshua A Kramer1, Brigitte E Sanders-Beer, Yvette Edghill Spano, Lowrey Rhodes, Keith G Mansfield.   

Abstract

An SIV-infected rhesus macaque presented with anemia, hypercalcemia, and hyperglobulinemia. Neoplastic round cells with plasma cell morphology infiltrated multiple organs and stained immunohistochemically positive for CD45, MUM1/IRF4, CD138, VS38C, and Kappa light chain and variably positive for CD20 and CD79a, consistent with a B-cell neoplasm with plasma cell differentiation.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh：

Year:  2011        PMID： 21401622      PMCID： PMC3098314          DOI： 10.1111/j.1600-0684.2011.00473.x

Source DB:  PubMed          Journal:  J Med Primatol        ISSN： 0047-2565            Impact factor:   0.667


  24 in total

1.  Immunophenotype of neoplastic plasma cells in AL amyloidosis.

Authors:  M Deshmukh; K Elderfield; A Rahemtulla; K N Naresh
Journal:  J Clin Pathol       Date:  2009-08       Impact factor: 3.411

2.  The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.

Authors:  Ashley P Ng; Andrew Wei; Dinesh Bhurani; Peter Chapple; Frank Feleppa; Surender Juneja
Journal:  Haematologica       Date:  2006-07       Impact factor: 9.941

3.  Immunohistochemical and histochemical stains for differentiating canine cutaneous round cell tumors.

Authors:  N J Fernandez; K H West; M L Jackson; B A Kidney
Journal:  Vet Pathol       Date:  2005-07       Impact factor: 2.221

Review 4.  Conventional diagnostics in multiple myeloma.

Authors:  Jesús F San Miguel; Norma C Gutiérrez; Gema Mateo; Alberto Orfao
Journal:  Eur J Cancer       Date:  2006-06-09       Impact factor: 9.162

Review 5.  The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy.

Authors:  Régis Bataille; Gaëtan Jégo; Nelly Robillard; Sophie Barillé-Nion; Jean-Luc Harousseau; Philippe Moreau; Martine Amiot; Catherine Pellat-Deceunynck
Journal:  Haematologica       Date:  2006-09       Impact factor: 9.941

Review 6.  Waldenström macroglobulinemia.

Authors:  Arun Vijay; Morie A Gertz
Journal:  Blood       Date:  2007-02-15       Impact factor: 22.113

Review 7.  Monoclonal gammopathy of undetermined significance.

Authors:  Robert A Kyle; S Vincent Rajkumar
Journal:  Clin Lymphoma Myeloma       Date:  2005-09

8.  Immunohistochemical detection of multiple myeloma 1/interferon regulatory factor 4 (MUM1/IRF-4) in canine plasmacytoma: comparison with CD79a and CD20.

Authors:  J A Ramos-Vara; M A Miller; V E O Valli
Journal:  Vet Pathol       Date:  2007-11       Impact factor: 2.221

Review 9.  Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis.

Authors:  Victor H Jimenez-Zepeda; Virginia J Dominguez-Martinez
Journal:  Int J Hematol       Date:  2009-03-27       Impact factor: 2.490

10.  Phenotypic variation in myocardial macrophage populations suggests a role for macrophage activation in SIV-associated cardiac disease.

Authors:  Jennifer H Yearley; Christine Pearson; Richard P Shannon; Keith G Mansfield
Journal:  AIDS Res Hum Retroviruses       Date:  2007-04       Impact factor: 2.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.